These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2758409)

  • 21. Estrogen receptor activation in relation to previous estrogen treatment in carcinoma corporis uteri heterotransplanted into nude mice.
    Horvath G; Fernö M; Cameron R; Ranstam J
    In Vivo; 1989; 3(2):93-7. PubMed ID: 2519844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P; Lykkesfeldt AE
    Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental endocrinotherapy with tamoxifen of human ovarian dysgerminoma transplanted into nude mice.
    Isonishi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2185-92. PubMed ID: 3429992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of female sex steroid hormones on human endometrial adenocarcinoma transplanted into nude mice].
    Miyawaki Y
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2607-16. PubMed ID: 2614195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.
    Brünner N; Bronzert D; Vindeløv LL; Rygaard K; Spang-Thomsen M; Lippman ME
    Cancer Res; 1989 Mar; 49(6):1515-20. PubMed ID: 2924304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
    Noguchi M; Tajiri K; Taniya T; Kumaki T; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 May; 90(5):780-5. PubMed ID: 2529423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estradiol induced changes in tumor growth and steroid receptor content in a heterotransplanted human endometrial adenocarcinoma.
    Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J
    In Vivo; 1991; 5(4):401-6. PubMed ID: 1810429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of tamoxifen and estradiol on the growth of human breast cancer cells in vitro.
    Arafah BM; Griffin P; Gordon NH; Pearson OH
    Cancer Res; 1986 Jul; 46(7):3268-72. PubMed ID: 3708561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen-mediated growth inhibition of human cholangiocarcinoma.
    Sampson LK; Vickers SM; Ying W; Phillips JO
    Cancer Res; 1997 May; 57(9):1743-9. PubMed ID: 9135018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 17 beta-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and in athymic mice.
    Feucht KA; Walker MJ; Das Gupta TK; Beattie CW
    Cancer Res; 1988 Dec; 48(24 Pt 1):7093-101. PubMed ID: 3191486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
    Jordan VC; Gottardis MM; Robinson SP; Friedl A
    J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid receptor expression in endometria from women treated with tamoxifen.
    Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
    Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
    Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone steroid receptor variation after tamoxifen administration in endometrial adenocarcinoma from postmenopausal patients.
    Di Fronzo G; Ronchi E; Cappelletti V; Luciani L; Coradini D; Oriana S; Miodini P; Andreola S
    Cancer Detect Prev; 1986; 9(3-4):323-30. PubMed ID: 3742507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of estradiol on estrogen receptor, progesterone receptor, and tyrosinase in hamster melanoma transplanted into athymic mice.
    Hitselberger MH; Schleicher RL; Beattie CW
    Cancer Res; 1988 Jul; 48(13):3720-7. PubMed ID: 3132319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short term treatment of tamoxifen and estradiol on estradiol and progesterone receptors in rabbit uterus.
    Bhargava S; Murugesan K; Vij U; Bharti A; Farooq A
    Indian J Exp Biol; 1993 Aug; 31(8):673-6. PubMed ID: 8270280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines.
    Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T
    Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro.
    Gottardis MM; Wagner RJ; Borden EC; Jordan VC
    Cancer Res; 1989 Sep; 49(17):4765-9. PubMed ID: 2758410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.